“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s article of the five Buy-rated stocks trading under $10 that he highlights. For these five stocks – which include a clinical-stage pharmaceutical company focused on the development of novel therapies for the treatment of serious and life-threatening rare respiratory diseases – CLICK HERE.
5 Stocks Under $10 Offering Solid Alpha Potential For Aggressive Investors
Tags:Aggressive InvestorsAlpha PotentialBuy-Rated StocksClinical-Stage Pharmaceutical Investmentsstock marketstocksStocks Under $10Upside Potential